1. Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer
   Yu Liu et al, 2019, Biomarkers in Medicine CrossRef
2. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma
   Fu Jun et al, 2020, Gynecologic Oncology CrossRef
3. Probing the methotrexate–protein interactions by proteomics and thermostability assay for drug resistance study
   Wenbo Zhang et al, 2021, Analytical Methods CrossRef
4. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach
   Nelson C. Soares et al, 2022, Journal of Proteomics CrossRef
5. miRNome of inflammatory breast cancer
   Diana V Maltseva et al, 2014, BMC Research Notes CrossRef
6. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics
   Hongwei Jin et al, 2016, Journal of Proteomics CrossRef
7. Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration
   Sana Kauser et al, 2023, Frontiers in Oncology CrossRef
8. Identification and Characterization of Immunogene-Related Alternative Splicing Patterns and Tumor Microenvironment Infiltration Patterns in Breast Cancer
   Shuang Guo et al, 2022, Cancers CrossRef
9. Efficient delivery of methotrexate to MDA-MB-231 breast cancer cells by a pH-responsive ZnO nanocarrier
   Jiko Raut et al, 2023, Scientific Reports CrossRef
10. Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF
    Angelina Boccarelli et al, 2023, Pathology - Research and Practice CrossRef
11. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2
    Xiaowei Zheng et al, 2015, Cancer Biology & Therapy CrossRef
12. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
    Xiaoling Qian et al, 2017, Oncotarget CrossRef
13. Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines
    Binayak Kumar et al, 2023, Molecular Omics CrossRef
14. PSMA2 knockdown impacts expression of proteins involved in immune and cellular stress responses in human lung cells
    Mahamud-ur Rashid et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
15. Targeting PGAM1 in cancer: An emerging therapeutic opportunity
    Guan-Jun Yang et al, 2022, European Journal of Medicinal Chemistry CrossRef
16. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer
    P. S. Thakur et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
17. Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma
    Siying Chen et al, 2018, Journal of Drug Targeting CrossRef
18. Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro
    Patrícia F. Lainetti et al, 2021, Molecules CrossRef
19. Could polymorphisms in ABCB1 gene represent a genetic risk factor for the development of mammary tumors in dogs?
    T. Maués et al, 2019, The Veterinary Journal CrossRef
20. Data from a comparative proteomic analysis of tumor-derived lung-cancer CD105+ endothelial cells
    Hongwei Jin et al, 2016, Data in Brief CrossRef
21. Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines
    Shi Qinghong et al, 2015, Proteome Science CrossRef
22. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer
    SI-YING CHEN et al, 2016, International Journal of Oncology CrossRef